CUA Educational Content

Evolution of adjuvant and front-line therapy in renal cell carcinoma

CUA Speaker Tour with Brian Rini

Moderators: Dominick Bossé & Christian Kollmannsberger


  • Understand the evolving landscape of adjuvant RCC therapy including recent data
  • Describe the standard of care in front-line RCC and appreciate current unanswered questions.
  • Appreciate recent triplet data in mRCC and ongoing trials in the front-line space.


This activity is an Accredited Self-Assessment Program (Section 3) as defined by the Maintenance of Certification Program of the Royal College of Physicians and Surgeons of Canada, and approved by CUA. You may claim a maximum of 1 hour of credit.


This program has received financial support from Pfizer in the form of an educational grant.